Spots Global Cancer Trial Database for A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

Official Title: An Open-label Phase 1 Study of E7386 in Subjects With Advanced Solid Tumor Including Colorectal Cancer

Study ID: NCT03833700

Conditions

Solid Neoplasms

Colorectal Neoplasms

Gastrointestinal Tumors

Interventions

E7386

Study Description

Brief Summary: The primary objective of this study is to assess the safety and tolerability of E7386 in participants with solid tumor including CRC.

Detailed Description: The study will be conducted in 3 parts: dose escalation part, expansion part 1 and expansion part 2. The study will include Pre-treatment Phase, Treatment Phase, and Extension Phase (in expansion parts only). Eligible participants from Pre-Treatment Phase (screening period) will enter into the Treatment Phase to receive E7386. After Treatment Phase, participants will be followed in follow-up period of Extension Phase (in expansion parts only).